- Report
- October 2023
- 80 Pages
Ireland
From €1386EUR$1,500USD£1,166GBP
- Report
- October 2023
- 80 Pages
Brazil
From €1386EUR$1,500USD£1,166GBP
- Report
- October 2023
- 80 Pages
Argentina
From €1386EUR$1,500USD£1,166GBP
- Report
- October 2024
- 70 Pages
Global
From €878EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
North America
From €878EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €878EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
Europe
From €878EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
Japan
From €878EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
United States
From €878EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €878EUR$950USD£739GBP
- Report
- February 2024
- 132 Pages
Global
From €878EUR$950USD£739GBP
- Report
- May 2023
- 250 Pages
Global
From €2309EUR$2,499USD£1,943GBP
€3299EUR$3,570USD£2,776GBP
- Report
- March 2023
- 428 Pages
Global
From €2387EUR$2,583USD£2,008GBP
€3410EUR$3,690USD£2,869GBP
- Report
- October 2022
- 226 Pages
Global
From €2309EUR$2,499USD£1,943GBP
€3299EUR$3,570USD£2,776GBP
- Report
- February 2022
- 230 Pages
Global
From €2401EUR$2,598USD£2,020GBP
€3430EUR$3,712USD£2,886GBP
- Report
- October 2021
- 112 Pages
India
From €2401EUR$2,598USD£2,020GBP
€3430EUR$3,712USD£2,886GBP
- Report
- April 2022
- 120 Pages
Global
From €2236EUR$2,419USD£1,881GBP
€3194EUR$3,456USD£2,687GBP
- Report
- August 2021
- 195 Pages
Global
From €2401EUR$2,598USD£2,020GBP
€3430EUR$3,712USD£2,886GBP
- Book
- April 2019
- 240 Pages
- Book
- April 2010
- 192 Pages

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more